Chimerix (CMRX)
(Delayed Data from NSDQ)
$0.90 USD
+0.01 (1.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.89 -0.01 (-1.10%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CMRX 0.90 +0.01(1.00%)
Will CMRX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CMRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CMRX
Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates
Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
CMRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chimerix (CMRX) Reports Q1 Loss, Misses Revenue Estimates
Chimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Green Thumb Industries Inc. (GTBIF) Q4 Earnings Lag Estimates
Other News for CMRX
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biotech Alert: Searches spiking for these stocks today
Chimerix Board Changes: Machado Resigns, Kozin Appointed
Chimerix Appoints Marc D. Kozin to Board of Directors